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ABSTRACT 
 
 The hypoglycemic effect of ethanolic extract of Aloe vera was 
studied on hyperglycemic and normal Wister albino rats. 
The oral administration of 10 mg/kg B.wt of glibenclamide, 
(hypoglycemic drug), and two different concentrations 100, 500 
mg/kg.B.wt Aloe vera extract to glucose loaded rats (2 mg/kg of 50% 
glucose solution) showed a lowering effect on blood glucose level 
compared to the control group. It was significant (P< 0.01) at a dose 
of 500 mg/kgB.wt 2 hours after treatment.   
Similar doses of Aloe vera extract orally administrated to 
normal rats for six days, has no significant lowering effect in plasma 
glucose level of animals. However, there were a significant  reduction 
in body weight of rats received the Aloe vera but there were no 
significant effect on the relative livers weights. Histologically the liver 
were normal but there were increased on globet cell in the intestine.  
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  ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﺔ
  
  ﺒﻼﺯﻤﺎ ﺍﻟﺠﻠﻭﻜﻭﺯ ﻓﻲ  ﻤﺴﺘﻭﻯ ﻫﺫﻩ ﺍﻷﻁﺭﻭﺤﺔ ﺘﻤﺕ ﺩﺭﺍﺴﺔ ﺍﻷﺜﺭ ﺍﻟﺨﺎﻓﺽ ﻟﻨﺴﺒﺔ ﻓﻲ 
  .(ﻗﻼﻴﺒﻨﻜﻼﻤﺎﻴﺩ) ﻤﻘﺎﺭﻨﺔ ﻤﻊ ﺩﻭﺍﺀ ﺍﻟﺴﻜﺭﻯ  ﻋﻠﻰ ﺠﺭﺫﺍﻥ ﻤﻭﻟﺩﻩﺍﻟﺩﻡ ﻟﻨﺒﺎﺕ ﺍﻟﺼﺒﺎﺭ
ﻜﻠﺠـﻡ ﻤـﻥ / ﻤﻠﺠـﻡ 2ﻟﺠﺭﺫﺍﻥ ﺤﻘﻨـﺕ  ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻜﺤﻭﻟﻲ ﻟﻠﺼﺒﺎﺭ ﺍﻋﻁﻰ
 ,  ﺠﺭﻋﺘﻴﻥ ﻤﺨﺘﻠﻔﺘـﻴﻥ ﻋﻠﻰﻭﺃﺨـﺭﻯ ﻁﺒﻴﻌﻴـﺔ %( 05)ﻭﺯ ـﺍﻟﺠﻠﻭﻜﻭل ـﻤﺤﻠ
  ﻓﻘـﺩ ﺍﻋﻁـﻰ ﻗﻼﻴﺒﻨﻜﻼﻤﺎﻴﺩ ﺍﻤﺎ, ﻜﺠﻡ ﻤﻥ ﻭﺯﻥ ﺍﻟﺤﻴﻭﺍﻥ ﺍﻟﺤﻲ /ﺠﻡﻠ ﻤ 005 ﻭ 001
 ﺍﻟﺠﻠﻭﻜﻭﺯ  ﻤﺴﺘﻭﻯ  ﻨﺴﺒﺔ ﺽﺍﻨﺨﻔﺎﺘﺴﺒﺏ ﺍﻟﻤﺴﺘﺨﻠﺹ ﻓﻲ .  ﻜﺠﻡ/ﺠﻡﻠﻤ 01 ﺠﺭﻋﺔﺒ
 ﻭﻗﺩ ﺒﻠﻐﺕ ﺃﻋﻠﻲ ﻭﺯـﺍﻟﺠﻠﻭﻜﻤﺤﻠـﻭل   ﺍﻟﺘﻰ ﺍﻋﻁﻴﺕ ﻓﻰ ﺍﻟﺠـﺭﺫﺍﻥ  ﻓﻲ ﺒﻼﺯﻤﺎ ﺍﻟﺩﻡ 
 ﺍﻤﺎ ﺍﻟﺠﺭﻋﺔ  ﻜﺠﻡ/ ﻤﺠﻡ 005ﻨﺴﺒﺔ ﺍﻨﺨﻔﺎﺽ ﺒﻌﺩ ﻤﺭﻭﺭ ﺴﺎﻋﺘﻴﻥ ﻓﻲ ﺤﺎﻟﺔ ﺍﻟﺠﺭﻋﺔ 
  ﻴﺤﺩﺙ ﺘﻐﻴﺭ ﻓـﻰ ﻟﻡ. ﻴﺒﻨﻜﻼﻤﺎﻴﺩﺍﻟﻘﻼ ﻓﺎﻥ ﺍﻟﺘﺎﺜﻴﺭ ﻜﺎﻥ ﻤﺴﺎﻭﻴﺎ ﻟﺘﺎﺜﻴﺭ ﻜﺠﻡ/ﻤﺠﻡ 001
  .ﻁﺒﻴﻌﻴﺔﺍﻟﺠﺭﺫﺍﻥ ﻟﺍﺩﻡ  ﺍﻟﺠﻠﻭﻜﻭﺯ ﻓﻲ  ﻤﺴﺘﻭﻯﻨﺴﺒﺔ
 ﺹ ﻤﺴﺘﺨﻠ ﺕﺍﻋﻁ  ﺍﻟﺘﻰ ﻁﺒﻴﻌﻴﺔﺍﻟ  ﺍﻨﺨﻔﺎﺽ ﻤﻌﻨﻭﻱ ﻻﻭﺯﺍﻥ ﺍﻟﺠﺭﺫﺍﻥ ﺤﺩﺙ
 ,ﺍﻟﻨﺴﺒﻲ  ﻭﺯﻥ ﺍﻟﻜﺒﺩ ﻓﻲﺤﺩﺙ ﺃﻱ ﺘﻐﻴﻴﺭ ﻤﻌﻨﻭﻱ ﻴ ﻟﻡ  ﺍﻴﺎﻡ ﻟﻜﻥ 6 ﻟﻤﺩﺓ ﻨﺒﺎﺕ ﺍﻟﺼﺒﺎﺭ 
ﻋـﺩﺍ ﺍﻟﺘﻲ ﺘﻡ ﻓﺤﺼﻬﺎ   ﺍﻷﻋﻀﺎﺀ ﺍﻷﻨﺴﺠﺔ ﻓﻲ ﻓﻲ ﻤﺭﻀﻴﺔ  ﺃﻱ ﺘﻐﻴﺭﺍﺕ ﺸﺎﻫﺩﻟﻡ ﺘ 
  .ﺍﻟﻜﺎﺴﻴﺔ ﻓﻲ ﺍﻷﻤﻌﺎﺀﺨﻼﻴﺎ ﺍﻟﺯﻴﺎﺩﺓ ﻓﻲ ﻋﺩﺩ 
ﻥ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻜﺤﻭﻟﻲ ﻟﻨﺒﺎﺕ ﺍﻟﺼﺒﺎﺭ ﻗﺩ ﺘﻜـﻭﻥ ﻟـﻪ ﺃﺫﻟﻙ  ﻨﺴﺘﻨﺘﺞ ﻤﻥ 
  .  ﻋﻼﺝ ﺍﻟﺒﻭل ﺍﻟﺴﻜﺭﻱﺌﻴﺔ ﻓﻲ ﺃﻫﻤﻴﺔ ﺩﻭﺍ
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INTRODUCTION 
 Diabetes mellitus is one of the most famous and wide spreading 
diseases. It's a multifunctional disease with several causes and  
complex consequences. It remains an important risk factor for 
cardiovascular diseases and increasing rate of childhood and adult 
obesity. Diabetes is likely to become even more prevalent over the 
coming decade (National Diabetes, 1998). 
 Many drugs are used for treatment of diabetes like insulin, 
metformin, sulfonylurea and meglitinidines. Some of these drugs have 
side effects the main of which is an increased risk of hypoglycemia 
(Alpung et al., 1996). Hence many studies were carried out to 
investigate the hypoglycemia and anti-diabetic effect of many plants 
used traditionally to treat diabetes.  
 The used medicinal plants in the treatment of diabetes mellitus 
are a common practice in a wide areas of Sudan especially in Western 
States where people depends solely on herbal treatment (Hassan, 
2002). 
 There is a great need for evaluation and identification of active 
ingredients, and the mode of action and safty of the herbs used in folk 
medicine. 
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 Aloe vera is a perennial plant, belonging to family Liliaceae that 
used in folk medicine as a remedy for their various medicinal 
properties (Klein, 1995). There have been controversial reports on the 
hypoglycemic activity of Aloe species, probably due to differences in 
the parts of the plant used or to the model of diabetes chosen (Okyar, 
et al., 2001). 
 The present study was carried out to achieve the following: 
1. To study the effect of Aloe vera ethanolic extracts in blood 
glucose level on normal and glucose loaded rats.  
2. To follow up its effect on some vital organs such as liver, 
spleen, kidney, lungs, heart, brain and gastrointestesial tract.  
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CHAPTER ONE 
LITERAURE REVIEW 
1.1 Diabetes mellitus: 
Diabetes mellitus is a serious chronic metabolic disorder that 
has a significant impact on the health, quality of life, and life 
expectancy of patients, as well on the health care system (Bethesda, 
1995). It is divided into two major categories: Type I diabetes, 
formerly known as insulin-dependant diabetes mellitus or IDDM, and 
type II diabetes formerly known as non insulin-dependant diabetes 
mellitus or NIDDM, (Diabetes, 1996). 
Diabetes Care (1997) stated that type II diabetes represents a 
syndrome with disordered metabolism of carbohydrate and fat and 
that the most prominent clinical feature is hyperglycemia. 
However, the disturbance in carbohydrates metabolism is due to 
the fact that liver and skeletal muscles can not store glycogen, and the 
muscles are unable to utilize glucose. When the kidney threshold for 
glucose is exceeded, glucosuria occurs with consequent increase of 
water excretion and disturbance of electrolytes and water balance. 
(Gilman’s et al., 1992). 
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         Wilson et al. (1975) reported that the amount of fats metabolized 
by the diabetic patient is excessive, and since normal fat catabolism 
can only proceeds at a limited rate, ketone bodies are present in the 
blood and the urine as ß-hydroxybutyric acid, acetone-acetic acid and 
acetone in the breath. 
Most important pathological process during the development of 
diabetes involves three key organs; namely pancreatic islets, liver and 
skeletal muscle. Almost all anti diabetic therapies are aimed at these 
organs. Pharmacological treatment is indicated when fasting glucose 
level exceeds 140 mg/dl and the postprandial glucose level exceeds 
160 mg/dl (Defronzo, 1999). 
1.2 Pharmacological Treatment: 
1.2.1 Oral Glucose-Lowering Drugs: 
Oral therapy by conventional standards is indicated in any 
patient with type II diabetes in whom diet and exercise fail to achieve 
acceptable glycemic control (Defronzo, 1999).  
        Although initial responses may be acceptable, oral hypoglycemic 
drugs may be unaffected in a significant percentage of patients.  
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Five classes of oral agents are approved for the treatment of 
type II diabetes includes sulfonylureas, biguanides, alpha-glucosidase 
inhibitors, Thiazolidinediones and meglitindes.  
The Sulphonylureas include first generation e.g. tolbutamide 
and second generation e.g. glyburide (glibenclamide). It enhances 
insulin secretion from the pancreatic beta cells by increasing the 
sensitivity of peripheral tissue to insulin. These drugs are in-effective 
in pancreatectomized animals or patients, and in diabetic patients who 
have no endogenous insulin (Gilman’s et al., 1992). 
The Biguanides include the drug metaformin which originally 
derived from a medicinal plant Galega officinalis. Metaformin 
reduces plasma glucose via inhibition of hepatic glucose production 
and increase of muscle glucose uptake. It also reduces plasma 
triglycerides and LDL-cholesterol levels. However, the drug has side 
effects include weakness, fatigue, shortness of breath, nausea, lactic 
acidosis and kidney toxicity (Kelly, 1999). 
Alpha glucosidase inhibitor include the drugs acarbose. This 
drug category decreases post prandial glucose levels by interfering 
with carbohydrates digestion and delaying gastrointestinal absorption 
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of glucose. The major side effects are gas, bloating and diarrhea 
(Defronzo, 1999).  
Thiazolidinediones an expensive oral agents work by improving 
insulin sensitivity in muscle and to a much lesser extent, in the liver. 
These drugs decrease plasma triglyceride levels, but such decrease 
may be associated with weight gain and increase in LDl cholostral 
levels (American Diabetes Association, 1994). 
         Meglitinides (drug name Repaglinide) augment insulin secretion, 
but increase in weight gain, gastrointestinal disturbances and 
hypoglycemia are possible side effects (American Diabetes 
Association, 1995).    
1.2.2 The Insulin Therapy:  
It's usually added to an oral agent when glycemic control is 
suboptimal at maximal doses of oral medications (Defronzo, 1999). 
Weight gain and hypoglycemia are common side effects of insulin 
therapy (Sinha et al., 1996). 
1.3 Medicinal Herbs: 
Many conventional drugs have been derived from prototypic 
molecules in medicinal plants. Over 400 traditional plants have been 
reported for the treatments of diabetes. However, only a small 
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numbers of these have received scientific and medical evaluation to 
assess their efficacy (Bailey and Day, 1989). The hypoglycemic effect 
of some herbal extracts has been conformed in human and animal 
model for type II diabetes (Keighley, 1999). The World Health 
Organization Expert Committee on diabetes has recommended further 
investigations and traditional medicinal herbs.  
There is some clinical evidence on Ginseng's hypoglycemic 
activity. Sotaniemi et al. (1995) demonstrated a reduction in levels of 
fasting blood glucose and HbAic in type II diabetes treated with small 
dose, 100-200 mg, of Ginseng relative to placebo. Principal 
components are believed to be triterpenoid, saponin and glycosides 
namely ginsenoside or panaxosides. Hypoglycemic effects have been 
shown in streptozotcin rat models (Shapiro, and Gong 2002). Shane 
and Whorter (2001) reported that the mechanisms of action of 
Ginseng may include decreased rate of carbohydrate absorption into 
the portal hepatic circulation, increase glucose transport and uptake 
mediated by nitric oxide, increased glycogen storage, and modulation 
of insulin secretion.       
Momordica charantia (Bitter Melon) has been used intensively 
in folk medicine as a remedy for diabetes. The blood sugar-lowering 
 8
action after the fresh juice fruit has been established in animal 
experimental models as well as human clinical trials (Welihinda et al., 
1986). Serivastara et al. (1993) postulated that the active components 
are thought to  be charantin, vicine and polypeptide-p (an unidentified 
insulin-like protein similar to bovine insulin). Theoretically 
mechanisms of action may include increased insulin secretion, tissue 
glucose up take, liver muscle glycogen synthesis, glucose oxidation, 
and decreased hepatic gluconeogenesis. Studies by Akhtar et al. 
(1981) in alloxan-induced diabetic rabbits have suggested hypo-
glycemic effects of Momordica charantia.    
         Trigonella foenum-graceum is another remedy used for diabetes. 
In type II diabetic patients, the ingestion of 15g of powdered 
fenugreek seeds soaked in water significantly reduced postprandial 
glucose level during the glucose tolerance test (Madar et al., 1988). 
Reported mechanisms of action include delay of gastric emptying, 
slowing carbohydrate absorption, and inhibition of glucose transport 
from the fiber content, as well as increased erythrocyte insulin 
receptors and modulation of peripheral glucose utilization. Many 
studies in alloxan-rat models have shown modulates exocrine 
pancteatic secretion (Sharma, 1990).   
 9
Gymnema sylvestra, a native plant to the tropical forests of 
India, has long been used as treatment for diabetes. In a study of type 
II diabetes, 22 patients were given 400 mg of Gymnema sylvestre  
extract daily along with their oral hypoglycemic drugs. All patients 
demonstrated improved blood sugar control (Baskaran et al., 1990). 
Studies of an ethanol of Gymnema sylvestre leaf extract in diabetic   
rat and rabbit models have reported regeneration of islets of 
Langerhans which decreases blood glucose, and increases serum 
insulin (Shanmugasundaram, et al., 1990a). Mechanism of action is 
unknown but postulated theories include increase in glucose uptake 
and utilization, increase in insulin release through cell permeability, 
increase in B-cell number, and stimulation B-cell function (Persaud   
et al., 1999). 
Shane and Whorter (2001) reported that both Allium cepa 
(onions) and Allium sativum (garlic) have blood sugar lowering 
effects. Volatile oils in raw onion and garlic cloves have been shown 
to lower fasting glucose concentration in both diabetic animals and 
human (Jain et al., 1973). The active components of these plants are 
believed to be sulfur-containing compounds –allyl propyl disulfide 
(APDS) and daily disulfide (allicin) in garlic. Sheela and Augusti 
(1992) have postulated that these active ingredients lower glucose 
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level by competing with insulin (which is also a disulfide) for insulin 
inactivating site in the liver, resulting in an increase of free insulin. A 
typical dosage of Allium cepa is a 400 mg capsule daily. The general 
daily dosage of garlic is 4 g fresh garlic or 8 mg essential oil 
(Gruenwald et al., 2000). Experiments for Allium sativum in animal 
models with alloxan-induced diabetes have shown moderate 
reductions in blood glucose; no effect is seen in pancreatectomized 
animals (Sheela and Augusti 1992). 
Ficus carica is a popular plant used by patients with diabetes in 
south Western Europe. Its component is unknown. Several studies on 
animal models with diabetes have shown both short – and long term 
hypoglycemic effects, although human trials are lacking. Potential 
Hypolipidemic effects in diabetic animal have also been shown 
(Perez, et al., 1996). The mechanism of Ficus carica for glucose 
effect is unknown; however, some studies suggest facilitation of 
glucose uptake peripherally (American Diabetes Association, 2003).  
1.4 Aloe vera:  
It's a short-teemed succulent perennial herb, belonging to the 
family of Liliaceae (Klein, 1988). Taxonomists refer to Aloe 
barbadensis as Aloe vera (Coats, 1979). Aloe is the one of the few 
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medicinal plants that has maintained its popularity for long period of 
time.  
The succulent leaves are crowded on the top of their stems, 
spreading grayish green and glaucous, spotted when young. It is      
20-50 cm long, 3-5 cm wide at the base, tapering gradually to the 
pointed tip and 1-2.5 cm thick. It has spiny edges and bitter latex 
inside (Fig. 1). 
It is native to North Africa (tropical), but now cultivated in 
warm clime areas of Asia, Europe and America. It has been 
extensively cultivated in Caribbean Islands and Maurice since the 
early 1800s. 
1.4.1 Chemical composition and active constituents: 
The Aloe plant is the source of two herbal preparations: Aloe 
gel (AG) and Latex. Aloe gel is often called Aloe vera and refers to 
the clear gel or mucilaginous substance produced by parenchymal 
cells located in the central region of the leaf. The diluted Aloe gel is 
commonly referred to as Aloe vera extract (Shelton 1991).  
The gel is composed mainly of water (99%) and mono-and 
polysaccharides (25% of the dry weight of the gel). The most 
prominent  monosaccharide  in Aloe gel is mannose-6 phosphate,  and 
 12
 
 
 
 
 
 
 
 
 
 
Fig. (1): Aloe vera 
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the most common polysaccharides are gluco-mannans (beta-1, 4 
acetylated  mannan)  (Shelton, 1991).  Gluco-mannans  are long-chain 
sugars containing glucose and mannose. A prominent gluco-mannan 
named acemannan has been isolated and has been marketed as 
Currisyn (Wendell, 2006).  
A glycoprotein with anti allergic properties, called alprogen was 
isolated from Aloe gel (Lee, 2000). 
In addition a new anti-inflammatory compound, C-glucosyl 
chromone, has been isolated from Aloe gel (Hutter and Salmon 1996). 
 Sabeh and Wright (1993) found that Aloe gel contains lignan, 
salicylic acid, saponins, sterols, steroids, and triterpenoids. The fresh 
gel contains the proteolytic enzyme carboxypeptidase which breaks 
down bradykinin and glutathione peroxidase, as well as several 
isozymes of superoxide dismatase. 
Shelton (1991) was demonstrated that the gel also contains 
vitamins A, C, E, B12, Thiamine, niacin and folic acid as well as  the 
minerals: sodium, potassium, calcium, magnesium, manganese, 
copper, zinc, chromium and iron.  
The pericyclic tubular cells beneath the outer leaf epidermis 
produce a bitter yellow substance known as Aloe latex, commonly 
referred to as “aloe juice” or aloe, this substance is usually dried and 
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used as a potent stimulant laxative. Aloe latex contains a series of 
glycosides known as anthraquinones, the most prominent being aloe in 
A and B (Tyler, 1994). 
Aloe gel is often contaminated with Aloe latex during its 
isolation. This could explain the abdominal cramps, diarrhea and 
laxative effects some times seen with certain Aloe gel preparation 
(Wendlle, 2006). 
1.4.2 Pharmacology and Medicinal Uses: 
Aloe vera was used in local medicine for different treatments. 
Topically Aloe is used in: burn healing, genital herpes, seborrhea, 
cancer treatment support by preventing side effects of radiation 
therapy. Orally it used in diabetes immune support and ulcers. Aloe 
gel has long been used both externally and internally for its beneficial 
effects on the wound-healing process. Both topical and oral Aloe gel 
has been shown to significantly stimulate collagen synthesis on 
experimental dermal wounds in rats (Chithra  and Sajithlal, 1998). 
However, Aloe appears to be ineffective for treating the burn-
like damage caused by radiation therapy for cancer (Rodriguez and 
Cruz, 1988). In other study by Bracken and Cuppage (1985), Aloe gel 
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was found ineffective in treating hydrofluoric acid induced burns in 
rats. 
In a human study by Visuthikosol and Chowchuen (1995), 27 
patients with partial thickness burn wounds were treated with topical 
Aloe gel or standard Vaseline gauze. The average healing time was 
18-19 days in the Vaseline-gauze treated wounds while 11-29 days in 
the Aloe gel treated wounds. Histological examination showed early 
epithelialization in the Aloe gel treated skin areas. 
Vazquez and Avila (1996) reported that aqueous extract of Aloe 
gel was found to decrease Carrageen an-induced edema in a rat bind-
paw. Further, the extract reduced prostaglandin E2 production from 
(14 C) arachidonic acid via inhibition of cyclo-oxygenase. 
Many claims have been made throughout the years regarding 
Aloe vera's ability to support and enhance the immune system. 
Experimental evidence is now accumulating documenting immune-
stimulating constituents present in Aloe gel (Brossat, and Ledeaut, 
1981). 
Lee (2000) reported the isolation and partial purification of an 
antiallergic compound called alprogen from Aloe vera extracts. 
Alprogen was shown to inhibit the antigen-antibody reaction. They 
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postulated that the effect was via inhibition of Ca++ influx into mast 
cells. 
Several report indicated that antiviral and antitumor effects of 
Aloe vera are likely due to indirect stimulation of the immune system. 
However, one study reports that anthraquinones, which are present in 
Aloe latex, have direct virucidal effects (Wendlle, 2006). The 
anthraquinones (aloin) was shown to inactive various enveloped 
viruses, such as Herpes simplex, Varicella-Zoster, and Influenza. 
(Sydiskis and Owen, 1991). 
Anthraquinones present in Aloe latex function as a potent 
stimulant laxatives. Studies in rats have shown that aloe latex 
increases intestinal water content and stimulates mucus secretion   
(Kim and Kacew, 1999). Because of possible contamination by 
anthraquinones, oral Aloe vera may cause symptoms of abdominal 
crambs and diarrhea (Ajabnoor, 1990). However, long term use of the 
substance could result in electrolyte imbalances, especially depletion 
of potassium salts (Ishii and Tanizawa, 1994). 
Hunter and Frumkin (1991) reported that, in spite of the 
numerous uses of Aloe vera, side effects could be developed; 
occasional allergic skin reactions in a small number of people might 
be developed. Several patients who applied Aloe vera topically 
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following derm abrasion reported burning sensations and develop-
ment of dermatitis on the face. 
There have also been several reports of Aloe vera lowering 
plasma glucose levels in laboratory animals and in humans (Ajabnoor, 
1990). It was postulated in one study that this hypoglycemic effect 
was mediated through the simulation and release of insulin from the 
beta-cells of the pancreas. Therefore caution should be exercised when 
using oral Aloe vera in patients with diabetes (Ghannam et al., 1990). 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Materials: 
2.1.1 Plant: 
Aloe vera was collected from Khartoum Botanical Garden and 
authenticated by the botanists in Medicinal and Aromatic Plants 
Research Institute. Leaves were the part used in these experiments. 
2.1.2 Animals: 
Wister albino rats of either sex were used in the present study. 
The rats used for glucose tolerance (experiment I) were weighing    
90-150 g, while those used in experiment II for normoglycemic rats 
weighing 70-80 g. The rats were kept on cages and housed in standard 
environmental condition of temperature, humidity, light and a fixed 
diet at the premises of Medicinal and Aromatic Plants Research 
Institute. 
2.1.3 Diet:   
The composition of a maintenance diet giving to rats include, 
crude protein (18%), crude fiber (4.5%), crude fat (2.9%) and water 
(10%).  
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The analysis of the diet was made by the Environmental and 
Natural Resources Research Institute, National Center for Research, 
Khartoum, Sudan. 
2.1.4 Chemicals and reagents: 
- Glucose Kit, PLASMATEC Laboratory Products. 
- Ethanol. 
- Halothane, ZENICA Liited. 
- Hematoxylin. 
2.1.5 Instruments: 
- IEC-CENTRA-4B centrifuge. 
- Digital micropipette. 
- Heparinized capillary tubes. 
- UV/Visible range Spectrophotometer Model 6305. 
2.2 Experimental Design: 
2.2.1 Experiment I: The effect of Aloe vera ethanolic extract and 
glibenclamide on induced hyper-glycemic rats: 
This experiment was carried out to compare the effect of Aloe 
vera extract and the hypoglycemic drug glibenclamide on normal 
fasting rats.  Animals were divided randomly into 4 groups, 5 rats  
each. They were fasted for 18 hours. The plasma glucose level of the 
animals was determined at the zero hours. 50% glucose solution was 
injected intraperitonilly at adose of 2mg/Kg to all animals. Group A 
and B were used as controls. Group A was given 10 ml/Kg normal 
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distilled water, while group B was administrated glibenclamide orally 
at a rate of 10 mg/ Kg body weight (1mg/1ml w/v). Immediately after 
glucose injection, group C and D were administered orally with 
ethanolic  extract of Aloe vera (by gastric tube)  at rate of 100 mg, 500 
mg/kg body weight respectively. The plasma glucose level of the 
animals was measured at 1, 2 and 4 hours after glucose load       
(Table 2.1).                                                                                                                       
2.2.2 Experiment II: The effect of the ethanolic extract of Aloe vera 
on normal animals: 
Fifteen rats were randomly divided into 3 groups, 5 each. Group 
A was the control and received 10 ml distilled water. Group B and C 
were administered orally with ethanolic extract of Aloe vera at doses 
100 and 500 mg/Kg body weight respectively. Plasma glucose level 
and body weights of the animals were determined at the zero time and 
at the end of the experiment.  Animals were slaughtered and the liver 
weights were recorded. Livers, kidneys, spleens, lungs, gastro-
intestinal  and brain were fixed in 10% formalin for histological study 
(Table 2.2). 
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Table (2.1): Experimental design on the effect of Aloe vera extract on 
induced hyperglycemic Wister albino rats. 
Groups Dose 
(per Kg body weight) 
Treatment * 
(A) 10 ml Distilled water  
(B) 10 ml Glibenclamide  
(C) 100 mg Aloe vera ethanol extract  
(D) 500 mg Aloe vera ethanol extract  
 
* All rats were fasted for 18 hours and then injected with 50% glucose 
solution. 
 
 
Table (2.2): Experimental design on the effect of the ethanolic extract 
of Aloe vera on Wister albino rats.. 
 
Group Dose 
(Per Kg body weight) 
Treatment *  
(A) 10 ml Distilled water  
(B) 100 mg Aloe vera ethanol extract  
(C) 500 mg Aloe vera ethanol extract  
 
* The dose was administered for 6 days.  
 
 
 22
2.3 Methods: 
2.3.1 Preparation of the extract: 
Mature, healthy and fresh leaves of Aloe vera having length of 
approximately 75-90 cm were washed with fresh water. The leaves 
were cut transversely into pieces and dried in shade. 
141 g of air dried leaves of the plant were extracted using 95% 
ethanol. The filtrate was collected and evaporated, then kept in a 
beaker until it becomes dry and the weight was calculated. The residue 
was stored in dry small containers until further use. The plant water 
extract solution was prepared freshly each time and administrated 
intra-gastrically. 
2.3.2 Sample collection: 
1-2 ml of blood from the orbital plexus of the rats was drawn 
out by capillary tubes into fluorinated test tubes under inhalation 
anesthesia using halothane according to Khana et al. (1993). They 
were centrifuged at 3000 r.p.m. for 5 minutes to separate plasma. The 
plasma was used immediately to determine the glucose concentration. 
2.3.3 Body weight: 
 All animals were weighted at the beginning and the end of the 
experiment. 
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2.3.4 Glucose Oxidase Method: GOD/PAP 
The glucose concentration in plasma, a heparinized blood, was 
measured by an enzymatic method, according to Siest and Schielf 
(1981).  
Principle: 
Glucose is determined after enzymatic oxidation in the presence 
of glucose oxidase. The hydrogen peroxidase formed reacts, under 
catalysis of peroxidase, with phenol and 4-aminophenazone to form a 
red violet quinoneimine dye as indicator. 
Reaction: 
Glucose + O2 + H2O Glucose oxidase gluconic acid + H2O2 
2H2O2 + 4-aminophenazone  phenol peroxidase   quinoneimine + 4H2O 
2.3.4.3 The reagents consist of: 
Phosphate buffer  0.1 mol/L  pH: 7. 
Phenol   11 mmol/L. 
4-aminophenazone  0.77 mmol/L. 
Glucose oxidase  1.5 ku/L. 
Peroxidase   1.5 ku/L 
Standard glucose  100 mg/dl 
Procedure: 
20 µL of the standard or the sample were pipette into test tubes. 
Then 2000 µL of the reagent were added to each tube and mixed. 
They were incubated for 5 minutes at 37°C. The absorbance of the 
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standard (Astandard) and of the sample (Asample) were read a against the 
reagent blank at Wavelength 490 nm. 
Calculation: 
A (sample) Glucose concentration (mg/dl)= A(standard) 
X Standard concentration  
2.3.5 Histopathology:  
At the end of the second experimental period, animals were 
dissected and their organs were excised immediately. Small pieces 
were fixed in neutral formalin, dehydrated, cleared and embedded in 
paraffin wax. Sections of 6 µm were cut, mounted on clean slides and 
stained by hematoxylin and eosin (Drury and Wallington 1980). 
2.4 Statistical analysis: 
 All the grouped data were statistically evaluated with spps/7.5 
software. Hypothesis testing method included one-way analysis of 
variance (ANOV) followed by least significant difference (LSD) test; 
p values of less than 0.05 were considered to indicate statistical 
significance. All the results were expressed as the mean + SD for the 
five animals in each group.  
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CHAPTER THREE 
RESULTS 
 
3.1 The effect of Aloe vera ethanolic extract and glibenclamide on 
induced hyperglycemic rats. 
The blood glucose level on induced hyperglycemic rats is 
presented in Table (3.1) Figure (2). After one hour all groups showed 
an increase in the plasma glucose level compared to zero level, The 
increase in the control (group A) was 51%, while group (B) which 
received 10mg/kg B.wt glibenclamide the increase was 43.7%. 
However the groups received 100 mg/kg (C) and 500 mg/kg (D) Aloe 
vera extract the increase was 33.5% and 30.8% respectively. 
The glucose level after two hours compared to the one hour 
level was decreased in the control (group A) by 14.7%, while group 
(B) decrease was 16.4%. However group (C) and group (D) the 
decrease was 12.7% and 23.1% respectively. 
The glucose level was decreased gradually after four hours 
compared to the two hours level in the control (group A) by 37.5% to 
reach the starting level, while the reduction in groups (B) and (C) was 
11.5% and 5.8% respectively, they still remained above the starting 
level.  
 
 26
Table (3.1): The effect of the ethanolic extract of Aloe vera and 
glibenclamid on blood glucose level on induced 
hyperglycemic Wister albino rats. 
 
After glucose loaded  
Groups 
 Dose 
(Per Kg body 
weight) 
Starting 
level 1 hour 2 hours 4 hours 
(A) 10ml distilled 94.0 ±13.3 191.0 ±10.9 163.2± 8.8 102.0±10.3 
(B) 10 ml 
glibenclamid 
104.0±2.1 184.6±8.9 154.6±29.8* 136.8±18.3 
(C) 100 mg Aloe 
vera extract 
105.0±3.7 158.0±20.3 138.0±20.4* 130.0±20.0 
(D) 500 mg Aloe 
vera extract  
103.2±7.1 149.2±28.8 114.8±2.2** 102.8±12.6 
*   Significant at (P< 0.05)  
** Significant at (P< 0.01) 
 
 
 
Fig (2) The effect of the ethanolic extract of Aloe vera and glibenclamid on 
blood glucose level on induced hyperglycemia Wister albino rats 
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However group (D) that received 500 ml/kg B.wt Aloe vera 
extract tolerated the induced hyperglycemia the reduction was 10.1% 
and the glucose level was almost as the starting level. They 
hypoglycemic effect was significant at P< 0.01. 
3.2 The effect of ethanolic extract of Aloe vera on normal rats: 
3.2.1 Clinical signs: 
 The rats on groups received Aloe vera extract is exhibited 
watery diarrhea after two days and continued until the end of the 
experiment. It is profound in the group treated 500 mg Bw compared 
to that treated with 100 mg/kg Bw. The control group was normal. 
3.2.2 Body weight: 
Control rats (Group A) showed an increase in body weight 
through out the experimental period by 5.6%. Aloe vera treated groups 
(B) which received 100 mg/kg.B.wt. and (C) which received 500 
mg/kg.B.wt. showed significant decrease in body weight after the 
treatment period compared with that of control rats by 12.2 and 20.8% 
respectively (Table 3.2 and Figure 3). 
3.2.3 The ratio of the liver weight to body weight:  
There were no significant change in the ratio of the liver weight 
to body weight in the treated groups (B) and (C) compared with 
control group (A) (Table 3.3 and Figure 4). 
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Table (3.2): The effect of Aloe vera extract on body weight (g) of 
Wister albino rats. 
 
Groups 
Dose 
(Per Kg body 
weight) 
Starting 
day 6 day 
(A) 10ml distilled 
water 74.2 ± 4.1 78.6 ± 7.1 
(B) 100 mg Aloe 
vera extract 74.0 ± 6.2 65.0 ± 5.0
* 
(C) 500 mg Aloe 
vera extract  75.8 ± 5.9 60.0 ± 6.7
** 
 
* Significant at (P< 0.05) 
** Significant at (P< 0.01) 
 
Fig (3): The effect of Aloe vera extract on body weight (g) of normal 
Wister albino rats 
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Table (3.3): The effect of Aloe vera extract on liver weight ratio of 
Wister albino rats. 
 
Group Dose (Per Kg body weight)
Liver weight 
 (%) 
(A) 10 ml distilled water 2.0 ± 0.4 
(B) 100 mg Aloe vera 
extract    1.9 ± 0.4 
(C) 500 mg Aloe vera 
extract    2.1 ± 0.6 
 
 
 
 
Fig. (4): The effect of Aloe vera extract on liver weight of Wister    
                                                         albino rats 
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3.2.4 Glucose level  
After six days of treatment with ethanolic extract of Aloe vera 
on normal rats, no significant change was determined in blood glucose 
level in the treated groups compared with control. There was a slightly 
decrease in all groups in glucose level; in the control (group A) it was 
1.4% and in treated groups (B) and (C) it was 7.1 and 12% 
respectively (Table 3.4 and Figure 5).  
3.2.5 Histological results: 
 There were no pathological changes seen in all groups treated 
with Aloe vera extract (Fig. 6). There were an increased in goblet cells 
beside sloughing of the epithelial cells (Fig. 7, 8). 
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Table (3.4): The effect of Aloe vera extract on the plasma glucose 
level (mg/l) in Wister albino rats. 
 
Group Dose 
(Per Kg body 
weight) 
Starting day 6 days 
(A) 10ml  
Distilled water 88.0 ± 4.4 86.8 ± 10.3
(B) 100 mg  
Aloe vera extract 93.4 ± 10.1 86.8 ± 5.2 
(C) 500 mg  
Aloe vera extract  99.8 ± 11.8 87.8 ± 3.8 
 
 
 
 
 
Fig (5): The effect of Aloe vera extract on the plasma glucose level 
(mg/l) on Wister albino rats 
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Fig. (6): Pancreas of rats received 500 mg/kg Bw: Normal structure 
 
 
 
  
  
Fig. (7): Intestine from rats received 500 mg/kg Bw: increase goblet cells and 
sloughing of epithium. H & E x 10 
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Fig. (8): Intestine from rats received 500 mg/kg Bw: Higher manification of Fig. 
(7) H & E x 40 
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DISCUSSION 
 In the present study evaluation of administration of ethanolic 
extract of Aloe vera on glucose level was performed on induced 
hyperglycemic and normal rats to determine whether the extract has 
hypoglycemic properties.  
The effect of 500 mg/kg Body weight (Bw) Aloe vera ethanolic 
extracts on rats loaded with glucose was resulted in a significant drop 
in plasma glucose level. However 100 mg/kg of the extract lowered 
the glucose level in hyperglycemic rats by 12.7% compared to 23.1% 
in animals received 500 gm/kg. 
The same doses when administrated to normal rats showed 
slight alteration on the plasma glucose level on the rats which received 
500 mg/Kg body weight only.  
   These findings suggested that the hypoglycemic effect of Aloe 
vera was very clear in induced hyperglycemic rats, but it has little 
effects on normoglycemic animals. This is similar to the action of the 
biguanide group which is known as hypoglycemic drugs that do not 
cause hypoglycemia in normal subjects even when taken in excessive 
dose (Gilman et al., 1992). 
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             Blumenhal et al. (1998) reported that Aloe vera contained 
high calcium level which in turn stimulates the B-cells of langerhans 
that lead to an increase in liver glycogen level. 
Shane and Whorter (2001) Sated that Aloe vera gel obtained 
from the inner portion of the leaves contains glycomannan, a 
hydrosoluble which may account for its hypoglycemia effect.    
   The reduction of blood glucose level may be due to stimulation 
of the secretion of insulin by B cells and inhibition of α cells of the 
pancreatic islets or production of hyperglycemic factor or by 
enhancing insulin activity (Winkelman, 1989). The increase in insulin 
secretion may also be due to increase activity of glycogen synthesis as 
that induced by administration of garlic oil (Rawi et al., 1996) and 
Gymnea sylnestra extracts (Shanmugasundaram et al., 1990b). 
 Alsalahy and Hassanien (1993) studied the hypoglycemic effect 
of the extract of Allium sativum in normal and diabetic rats. They 
found, after seven days a significant reduction in blood glucose level 
and liver glycogen but an increase in muscles glycogen. The authors 
suggested that, Allium sativum may  enhance the uptake of glucose by 
muscles.  
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The histological investigation of organs showed no morpho-
logical difference between Aloe vera treated rats and control. This 
may  indicate that Aloe vera extract had no toxic effects on body 
weight in the body tissues, hence on pancreatic B-cells activity. Thus 
the decrease in serum glucose level caused by Aloe vera may either be  
due to increased carbohydrate utilization or enhancement of glucose 
uptake by muscles rather than stimulation of pancreatic B-cells. 
The reduction in body weight may be due to the effect of Aloe 
vera on the gastrointestinal tract which is evident by the presence of 
diarrhea. These finding is in agreement with Ishii and Tanizawa 
(1994) who suggested that the Aloe gel may be contaminate with Aloe 
latex during isolation and this could lead to diarrhea. The 
anthroquinone  glycosides in the Aloe latex reach the colon mostly 
undigested, although some are metabolized by enzymes produced by 
intestinal bacteria, the result include more frequent stools with softer 
consistency (Brusick and Mengs, 1997).  
In contrast to our findings Helal et al. (2003) and Takaka et al. 
(1996) reported that treatment of Aloe vera on the Alloxan induction 
of hyperglycemia improved the reduction in body weight.  
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The increase in goblet cells in the gastrointestinal tract may be 
caused by irritation of the extract this is harmony with Kim and 
Kacew (1999) who stated that the plant stimulates mucus secretion. 
In this study there were no significant change in the relative 
liver weight. This may be due to the fact that the extract extent no 
effect on the hepatocyts as evidence by histopathology, however the 
plant was administrated for a short period may play a role.  
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CONCLUSION 
 
It was concluded that 500 mg/kg body weight of Aloe vera 
ethanolic extract can successfully be used for lowering blood glucose 
in diabetics animals without side effects on the liver when used for 
short period of time. 
On the basis of the results obtained it can be concluded that the 
ethanolic extract of Aloe vera seems to possess hypoglycemic 
activities. Further studies are needed to evaluate the potential 
usefulness of this extract in clinical conditions associated with 
diabetes mellitus and it's mechanism of action. 
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